An inhibitory role for human CD96 endodomain in T Cell anti-tumor responses
Immune checkpoint blockade (ICB) therapy involves the inhibition of immune checkpoint regulators which reverses their limitation of T cell anti-tumor responses and results in long-lasting tumor regression. However, poor clinical response or tumor relapse was observed in some patients receiving such...
Saved in:
Main Authors: | Wang, Chelsia Qiuxia, Choy, Fong Chan, Sanny, Arleen, Murakami, Takashi, Tan, Andy Hee-Meng, Lam, Kong-Peng |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/169479 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
IMMUNOREGULATORY PROPERTIES OF CD137-CD137 LIGAND AXIS IN TUMOURS AND CHRONIC INFLAMMATORY CONDITIONS
by: LUU NGUYEN KHANG
Published: (2022) -
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
by: Wang, Dongdong, et al.
Published: (2023) -
The role of immunotherapy in the treatment of advanced cervical cancer: Current status and future perspectives
by: Walsh, RJ, et al.
Published: (2021) -
Targeting immune cells for cancer therapy
by: Gun, S.Y., et al.
Published: (2021) -
B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion
by: Luu, Khang, et al.
Published: (2022)